SCHEMBL1629980

SCHEMBL1629980

Cc1ccccc1-n1nccc1-c1ccc(O)cc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 8/20 0.49
NR3C2 P08235 1/20 0.46
MAPK14 Q16539 1/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
ALDH1A1 P00352 2/20 0.39
ESR2 Q92731 2/20 0.38
GAA P10253 2/20 0.38
MGAM O43451 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
HSP90AB1 P08238 1/20 0.38
ALOX5 P09917 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
USP2 O75604 1/20 0.38
POLB P06746 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630386 0.83 HSP90AA1 (0.51) HSP90AA1NR3C2ESR2MGAMHSP90AB1
SCHEMBL1629941 0.83 HSP90AA1 (0.67) HSP90AA1NR3C2MAPK14MAOBESR2
SCHEMBL1629812 0.83 HSP90AA1 (0.56) HSP90AA1NR3C2MAPK14MAOAMAOB
SCHEMBL1631545 0.83 HSP90AA1 (0.47) HSP90AA1NR3C2ESR2MGAMALOX5
SCHEMBL1630006 0.80 MAPT (0.45) HSP90AA1ALDH1A1GAAHSP90AB1ALOX5
SCHEMBL1630409 0.79 HSP90AA1 (0.51) HSP90AA1NR3C2ALDH1A1ESR2GAA
SCHEMBL1631441 0.78 HSP90AA1 (0.43) HSP90AA1ALDH1A1ESR2GAAMEN1
SCHEMBL1216327 0.78 HSP90AA1 (0.63) HSP90AA1NR3C2MAPK14ALDH1A1HSP90AB1
SCHEMBL1630527 0.77 HSP90AA1 (0.52) HSP90AA1NR3C2MAPK14ALDH1A1HSP90AB1
SCHEMBL1630444 0.77 ALDH1A1 (0.55) HSP90AA1NR3C2MAOAMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
EP-1776346-A1 1,5-DIPHENYLPYRAZOLES Merck Patent GmbH (DE) 2007-04-25 EP disclosed
WO-2006018082-A1 1,5-DIPHENYLPYRAZOLES MERCK PATENT GMBH (DE) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885NR3C2 558/4885MAPK14 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.